expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East MonitorNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology Today
RT.comSME.sk
South China Morning PostThe Asahi ShimbunThe DiplomatThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)Večer
العين الإخبارية 
Toi StaffEmanuel FabianJacob MagidAgenciesReuters
Gideon LevyThe Japan News EditorialLazar BermanGianluca PacchianiDavid Horovitz
Somdeep SenJeremy SharonLuke TressSam Sokol
Belen FernandezCanaan Lidor
Andrew MitrovicaAmérica EconomíaThe Asahi ShimbunRon KampeasSue SurkesAmanda Borschel-DanAmy SpiroZvi Bar&x27ElCathryn J. PrinceRenee Ghert-ZandHanin MajadliYuli TamirNatan OdenheimerDavid RothkopfCarolina LandsmannAndrew LapinAmira HassEtan NechinEran Yashiv
Ali Fathollah-NejadJessica SteinbergGavriel FiskeRachel MarsdenCharlie SummersB. MichaelWilliam Noah GlucroftNoa LandauAhmad IbsaisJames ShimanyulaMegan KangUri MisgavMartina JaureguyAnshel PfefferShin Nakayama
|
|
Paul ArmentanoThe Daily Caller |
Twelve years into states’ marijuana legalization experiment, public support for making marijuana legal nationwide has never been higher.
Reclassifying cannabis from Schedule I to a lower classification (like II or III) won’t bridge the widening gap between state and federal marijuana...
login
who are we?
contact us
qosheapp
